HKBU-led research team develops novel anti-viral targeted drug for nasopharyngeal cancer treatment
A research team led by Hong Kong Baptist University (HKBU) has developed a novel anti-Epstein-Barr virus (EBV) drug that can selectively disrupt a viral protein produced by EBV, leading to the shrinkage of tumours caused by the virus. It is the first...
New HKBU-led study unveils COVID-19 transmission patterns and safety-conscious reopening plans
With the COVID-19 pandemic resulting in lockdowns in different parts of the world, from the US to many European nations, there have been intense debates on when and how we can safely reopen the economy. New research led by HKBU computer...
New book by staff (5 February 2020)
05 Feb 2020
SCM scientists develop new method for Cordyceps sinensis authentication
17 Jan 2020
New book by staff (29 November 2019)
29 Nov 2019
HKBU spin-off company takes the lead and taps into the Greater Bay Area market
28 Nov 2019
History scholars win funding for online interactive historical map project
25 Nov 2019
New book by staff (1 November 2019)
01 Nov 2019